To gain further insights into the mechanisms by which NLRP3 disruption exerts its growth-inhibitory effects in AML cells, we performed whole-cell proteomics of MOLM-13 cells treated with the NLRP3 inhibitor CP-456773. The gene discussed is NLRP3; the disease is acute myeloid leukemia.